Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026)
Verano Holdings' (VRNO) quarterly Other Operating Expenses came in at -$27000.0 in Q1 2026, up 67.86% year-on-year from -$16085.1 in Q1 2025, and up 97.39% on a QoQ basis from -$1.0 million in Q4 2025.
Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Operating Expenses data on file, last reported at -$27000.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 67.86% year-over-year to -$27000.0 in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 82.72% decrease from a year earlier, with the FY2025 full-year figure at -$2.0 million, down 78.08% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$27000.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for VRNO reached as high as $1.4 million in Q3 2022 and fell as low as -$1.0 million in Q4 2025.
- Historically, Other Operating Expenses has averaged -$272062.5 across 5 years, with a median of -$291000.0 in 2023.
- Across the five-year window, Other Operating Expenses surged 16133.33% in 2022 and plunged 313.43% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at -$408000.0 in 2022, then sank by 39.22% to -$568000.0 in 2023, then soared by 38.73% to -$348000.0 in 2024, then slumped by 197.13% to -$1.0 million in 2025, then surged by 97.39% to -$27000.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$27000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$620000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,000.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -620,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Mar 31, 2025 | -84,000.00 |
| Dec 31, 2024 | -348,000.00 |
| Sep 30, 2024 | -604,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Dec 31, 2023 | -568,000.00 |
| Sep 30, 2023 | -234,000.00 |
| Jun 30, 2023 | -388,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -408,000.00 |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | -203,000.00 |
| Mar 31, 2022 | -990,000.00 |
| Dec 31, 2021 | -647,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -429,000.00 |